Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuefeng Ni

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Medicina Clinica|March 27, 2024
Smoking contribution to the global burden of metabolic disorder: A cluster analysisHua Zhong, Xuefeng Ni, Ruxuan Chen, et al.
Journal of Cardiovascular Development and Disease|February 26, 2026
Epicardial Adipose Tissue Volume and Left Atrial Remodeling: A J-Shaped Association in Older AdultsXinyue Zhao, Guangjian Wang, Xuefeng Ni, et al.
Journal of Nephrology|May 31, 2023
Successful living-related kidney transplantation in MYH9-related disorder with macrothrombocytopenia: lessons for the clinical nephrologistXue Li, Wei Wang, Xuefeng Ni, et al.
Pathology, Research and Practice|November 21, 2022
LncRNA HCG18 promotes M2 macrophage polarization to accelerate cetuximab resistance in colorectal cancer through regulating miR-365a-3p/FOXO1/CSF-1 axisCao Gao, Wenwei Hu, Jiemin Zhao, et al.
Medicine|December 20, 2019
Emergence of KRAS p.G13D mutation and acquired resistance to cetuximab in colorectal cancer with vulvar metastasis: A case reportWeiguang Qiang, Qinqin Wu, Xuefeng Ni, et al.
Frontiers in Oncology|July 11, 2022
Case Report: An Adolescent Soft Tissue Sarcoma With YWHAE-NUTM2B Fusion Is Effectively Treated With Combined Therapy of Epirubicin and AnlotinibJiajia He, Yanjie Xu, Xuefeng Ni, et al.
Cell Death Discovery|July 1, 2025
N6-methyladenosine modification of MEF2A weakens cetuximab sensitivity in colorectal cancer via PD-L1/SOX12 axisCao Gao, Jiajia He, Jiemin Zhao, et al.
Internal and Emergency Medicine|August 20, 2024
Protecting effects of smoking against COVID-19: a community-based retrospective cohort study in middle- and older-aged adultsXiaomeng Hou, Fulin Zheng, Likun Lu, et al.
Cytokine|January 13, 2026
Interferon-γ (IFNγ), a double-edge sword that affects prognoses in critically ill patients: A prospective studyGuangjian Wang, Hui Lian, Hongmin Zhang, et al.
Peerj|October 13, 2025
Predictive role of systemic immune-inflammation index in the prognosis of patients with advanced left-sided colorectal cancer: a retrospective studyJingyue Su, Shaokun Yu, Yanjie Xu, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Medicina Clinica|March 27, 2024
Smoking contribution to the global burden of metabolic disorder: A cluster analysisHua Zhong, Xuefeng Ni, Ruxuan Chen, et al.
Journal of Cardiovascular Development and Disease|February 26, 2026
Epicardial Adipose Tissue Volume and Left Atrial Remodeling: A J-Shaped Association in Older AdultsXinyue Zhao, Guangjian Wang, Xuefeng Ni, et al.
Journal of Nephrology|May 31, 2023
Successful living-related kidney transplantation in MYH9-related disorder with macrothrombocytopenia: lessons for the clinical nephrologistXue Li, Wei Wang, Xuefeng Ni, et al.
Pathology, Research and Practice|November 21, 2022
LncRNA HCG18 promotes M2 macrophage polarization to accelerate cetuximab resistance in colorectal cancer through regulating miR-365a-3p/FOXO1/CSF-1 axisCao Gao, Wenwei Hu, Jiemin Zhao, et al.
Medicine|December 20, 2019
Emergence of KRAS p.G13D mutation and acquired resistance to cetuximab in colorectal cancer with vulvar metastasis: A case reportWeiguang Qiang, Qinqin Wu, Xuefeng Ni, et al.
Frontiers in Oncology|July 11, 2022
Case Report: An Adolescent Soft Tissue Sarcoma With YWHAE-NUTM2B Fusion Is Effectively Treated With Combined Therapy of Epirubicin and AnlotinibJiajia He, Yanjie Xu, Xuefeng Ni, et al.
Cell Death Discovery|July 1, 2025
N6-methyladenosine modification of MEF2A weakens cetuximab sensitivity in colorectal cancer via PD-L1/SOX12 axisCao Gao, Jiajia He, Jiemin Zhao, et al.
Internal and Emergency Medicine|August 20, 2024
Protecting effects of smoking against COVID-19: a community-based retrospective cohort study in middle- and older-aged adultsXiaomeng Hou, Fulin Zheng, Likun Lu, et al.
Cytokine|January 13, 2026
Interferon-γ (IFNγ), a double-edge sword that affects prognoses in critically ill patients: A prospective studyGuangjian Wang, Hui Lian, Hongmin Zhang, et al.
Peerj|October 13, 2025
Predictive role of systemic immune-inflammation index in the prognosis of patients with advanced left-sided colorectal cancer: a retrospective studyJingyue Su, Shaokun Yu, Yanjie Xu, et al.
Pageof 4